Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 37 studies | 48% ± 22% | |
| endothelial cell of lymphatic vessel | 22 studies | 52% ± 21% | |
| capillary endothelial cell | 15 studies | 55% ± 23% | |
| endothelial cell of artery | 13 studies | 56% ± 17% | |
| vein endothelial cell | 12 studies | 57% ± 19% | |
| endothelial cell of vascular tree | 10 studies | 39% ± 22% | |
| pericyte | 7 studies | 34% ± 21% | |
| glomerular endothelial cell | 4 studies | 67% ± 8% | |
| type I pneumocyte | 4 studies | 23% ± 7% | |
| epithelial cell | 3 studies | 36% ± 10% | |
| basal cell | 3 studies | 39% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 27% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 4540.78 | 258 / 258 | 100% | 45.49 | 230 / 230 |
| uterus | 100% | 4709.88 | 170 / 170 | 100% | 37.39 | 459 / 459 |
| kidney | 100% | 4970.03 | 89 / 89 | 100% | 49.11 | 897 / 901 |
| thymus | 100% | 6756.78 | 653 / 653 | 100% | 62.09 | 602 / 605 |
| lung | 100% | 14739.29 | 578 / 578 | 99% | 36.47 | 1148 / 1155 |
| stomach | 100% | 2294.68 | 359 / 359 | 99% | 32.48 | 284 / 286 |
| breast | 100% | 6957.79 | 459 / 459 | 99% | 36.30 | 1109 / 1118 |
| esophagus | 100% | 2906.41 | 1441 / 1445 | 99% | 20.94 | 182 / 183 |
| skin | 100% | 2278.87 | 1800 / 1809 | 100% | 39.83 | 470 / 472 |
| bladder | 100% | 3579.48 | 21 / 21 | 99% | 39.85 | 499 / 504 |
| prostate | 100% | 3137.59 | 244 / 245 | 99% | 32.71 | 498 / 502 |
| intestine | 99% | 2451.07 | 953 / 966 | 99% | 38.23 | 521 / 527 |
| ovary | 96% | 2081.19 | 173 / 180 | 100% | 38.25 | 430 / 430 |
| liver | 80% | 1323.62 | 181 / 226 | 100% | 26.92 | 406 / 406 |
| pancreas | 75% | 994.10 | 247 / 328 | 100% | 46.07 | 178 / 178 |
| brain | 66% | 996.87 | 1754 / 2642 | 100% | 33.82 | 704 / 705 |
| adipose | 100% | 6801.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 23.47 | 29 / 29 |
| spleen | 100% | 24473.53 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 26.22 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 43.47 | 1 / 1 |
| heart | 98% | 3432.06 | 848 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 13.59 | 73 / 80 |
| blood vessel | 85% | 2173.08 | 1134 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 77% | 1155.92 | 619 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 27% | 343.86 | 255 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
| GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
| GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
| GO_0042117 | Biological process | monocyte activation |
| GO_0032755 | Biological process | positive regulation of interleukin-6 production |
| GO_0009615 | Biological process | response to virus |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0051607 | Biological process | defense response to virus |
| GO_0042307 | Biological process | positive regulation of protein import into nucleus |
| GO_0001822 | Biological process | kidney development |
| GO_0060586 | Biological process | multicellular organismal-level iron ion homeostasis |
| GO_0071347 | Biological process | cellular response to interleukin-1 |
| GO_0030214 | Biological process | hyaluronan catabolic process |
| GO_0010764 | Biological process | negative regulation of fibroblast migration |
| GO_0006027 | Biological process | glycosaminoglycan catabolic process |
| GO_0071493 | Biological process | cellular response to UV-B |
| GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
| GO_0071356 | Biological process | cellular response to tumor necrosis factor |
| GO_0046718 | Biological process | symbiont entry into host cell |
| GO_0070295 | Biological process | renal water absorption |
| GO_0019064 | Biological process | fusion of virus membrane with host plasma membrane |
| GO_0046677 | Biological process | response to antibiotic |
| GO_0032757 | Biological process | positive regulation of interleukin-8 production |
| GO_0000302 | Biological process | response to reactive oxygen species |
| GO_0061099 | Biological process | negative regulation of protein tyrosine kinase activity |
| GO_0043407 | Biological process | negative regulation of MAP kinase activity |
| GO_0050729 | Biological process | positive regulation of inflammatory response |
| GO_0051216 | Biological process | cartilage development |
| GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
| GO_0035810 | Biological process | positive regulation of urine volume |
| GO_0048705 | Biological process | skeletal system morphogenesis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0005902 | Cellular component | microvillus |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0045121 | Cellular component | membrane raft |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005764 | Cellular component | lysosome |
| GO_0009986 | Cellular component | cell surface |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0019899 | Molecular function | enzyme binding |
| GO_0030294 | Molecular function | receptor signaling protein tyrosine kinase inhibitor activity |
| GO_0004415 | Molecular function | hyalurononglucosaminidase activity |
| GO_0033906 | Molecular function | hyaluronoglucuronidase activity |
| GO_0001618 | Molecular function | virus receptor activity |
| GO_0050431 | Molecular function | transforming growth factor beta binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005540 | Molecular function | hyaluronic acid binding |
| GO_0030971 | Molecular function | receptor tyrosine kinase binding |
| Gene name | HYAL2 |
| Protein name | Hyaluronidase (EC 3.2.1.35) Hyaluronidase-2 (Hyal-2) (EC 3.2.1.35) (Hyaluronoglucosaminidase-2) (Lung carcinoma protein 2) (LuCa-2) Hyaluronoglucosaminidase 2 Hyaluronidase 2 |
| Synonyms | LUCA2 |
| Description | FUNCTION: Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Displays very low levels of activity. Associates with and negatively regulates MST1R. . FUNCTION: Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Displays very low levels of activity. Associates with and negatively regulates MST1R. . FUNCTION: Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Displays very low levels of activity. Associates with and negatively regulates MST1R. . FUNCTION: Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Displays very low levels of activity. Associates with and negatively regulates MST1R. . FUNCTION: Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Displays very low levels of activity. Associates with and negatively regulates MST1R. . FUNCTION: Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Displays very low levels of activity. Associates with and negatively regulates MST1R. . |
| Accessions | ENST00000442581.1 C9JSI7 Q12891 ENST00000424190.1 ENST00000395139.7 C9K016 ENST00000357750.9 C9JSD1 ENST00000428028.1 C9JBF5 ENST00000415028.1 ENST00000426286.1 Q5ZEZ9 ENST00000447092.5 Q5ZF00 C9J700 ENST00000458018.1 |